Cargando…
Biovigilance for the Quality and Safety of Medical Products of Human Origin
Progress in science and technology in the health services has led to the development of methods of regenerating and replacing solid organs, tissues and cells, using human body components to create medical products of human origin intended for clinical use. In the activities in which products of huma...
Autores principales: | Gkioka, Vasiliki, Tsirigotis, Panagiotis, Sarris, Markos, Soulis, Sotiris, Apostolou, Athanasios, Noutsias, Michel, Dimitriadis, Georgios, Kostakis, Alkiviadis, Boletis, Ioannis, Karabinis, Andreas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elmer Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6225864/ https://www.ncbi.nlm.nih.gov/pubmed/30425757 http://dx.doi.org/10.14740/jocmr3549w |
Ejemplares similares
-
Public Health Policies in European Union: An Innovation Strategy—Horizon 2020
por: Soulis, Sotiris, et al.
Publicado: (2015) -
Advanced Therapy Medicinal Products Challenges and Perspectives in Regenerative Medicine
por: Goula, Aspasia, et al.
Publicado: (2020) -
Biovigilance: A Global Perspective
por: Singh, Sukhjinder, et al.
Publicado: (2019) -
Establishing consensus on ethics, traceability and biovigilance for medical products of human origin
por: Ashford, Paul, et al.
Publicado: (2021) -
Safety and Biovigilance in Organ Donation (SAFEBOD): Protocol for a Population-Based Cohort Study
por: Rosales, Brenda, et al.
Publicado: (2020)